文献速递消化道肿瘤与早癌消化内镜

粪便免疫化学检测阴性后结肠镜癌症检出率低

Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-01-31

该回顾性队列研究纳入96,804例50-75岁初次粪便免疫化学检测(FIT)阴性且随后接受结肠镜的无症状平均风险者,发现每1000人中检出结直肠癌(CRC)1.4例,且与FIT次数无关;末次FIT后2年内检出率低(1.3/1000),超过2年则升高(4.4/1000)。

要点

  • FIT阴性后2年内CRC检出率低,尤其60岁以下人群。
  • CRC检出与既往FIT次数无关(P=.97)。
  • 年龄和末次FIT时间与CRC检出相关。

核心结论

  • 无症状平均风险者FIT阴性后2年内CRC不常见,多为非晚期,且与FIT次数无关。

主要发现

  • 257例诊断为CRC,其中102例无CRC危险因素记录,86例(84.3%)为非晚期CRC。
  • 400例对照中299例(74.75%;95%CI 70.49%-79.01%)缺乏CRC危险特征,估计72,263例(平均年龄57.5±7.0岁;54.5%女性)接受了筛查结肠镜。
  • 每1000人中检出CRC 1.4例,与FIT次数增加无关(P=.97)。
  • 末次FIT后2年内每1000人检出CRC 1.3例,超过2年检出4.4例(P<.001)。
  • 末次FIT在2年内时,CRC检出率从50-59岁的0.7/1000升至70岁以上的3.1/1000。

临床怎么用

  • FIT阴性后2年内可考虑延迟结肠镜,尤其60岁以下人群;超过2年检出率升高,应适时复查。

局限性

  • 回顾性设计,筛查结肠镜比例通过对照估计,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Screening colonoscopies are of uncertain benefit for persons with negative results from a fecal immunochemical test (FIT). We investigated detection of CRC by colonoscopy in asymptomatic, average-risk, FIT-negative subjects. METHODS: We conducted a retrospective, population-based cohort study of 96,804 subjects with an initial negative result from a FIT at ages 50-75 years, from 2008 through 2014, who then underwent colonoscopy, using the Kaiser Permanente California databases. We identified participants diagnosed with CRC from January 1, 2008 through December 31, 2015 from a cancer registry. Subjects were followed until initial colonoscopy, health plan disenrollment, death, or December 31, 2015. We reviewed records from 400 randomly selected persons without CRC (controls) for risk features to estimate the proportion who underwent screening colonoscopy. We performed logistic regression to identify variables associated with CRC detection. RESULTS: Of 257 subjects with a diagnosis of CRC, 102 did not have a record of CRC risk factors; 86 of these patients (84.3%) had non-advanced-stage CRC (no regional node spread/distant metastases). Of the 400 controls, 299 (74.75%; 95% CI, 70.49%-79.01%) lacked CRC risk features, enabling estimation that 72,263 (mean age, 57.5 ± 7.0 y; 54.5% female) had undergone screening colonoscopy. CRC was detected in 1.4 per 1000 persons after 1 FIT, without association with increasing FITs (P = .97). CRC was detected in 1.3 per 1000 persons in 2 y or less after the last FIT and in 4.4 per 1000 persons more than 2 y after the last FIT (P < .001). When the last FIT was 2 y earlier or less, CRC increased from 0.7 per 1000 persons age 50-59 y to 3.1 per 1000 persons older than 70 y. Age and time from the last FIT were associated with CRC, with adjusted odds ratios of 1.08 (95% CI, 1.05-1.11) and 2.76 (95% CI, 1.28-5.95), respectively. CONCLUSIONS: In asymptomatic, average-risk persons with a negative result from a FIT, CRC is infrequent within 2 y after the last FIT (especially for persons younger than 60 y), usually non-advanced, and unrelated to the number of FITs performed.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Longstreth GF, Anderson DS, Zisook DS, et al. Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests. Clin Gastroenterol Hepatol. 2020. PMID: 32007541. doi:10.1016/j.cgh.2020.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。